| Bioactivity | Deriglidole is a peripheral adrenoceptor antagonist with a high affinity for α2-adrenoceptors. |
| Target | Adrenoceptor |
| Invitro | Deriglidole is a selective α2-receptor inhibitor. Deriglidole inhibits [3H]Clonidine and [3H]Idazoxan but not [3H]Prazosin binding to rat cortical and human platelet α2-adrenoceptors and is more selective than Idazoxan for peripheral receptors[1]. |
| Name | Deriglidole |
| CAS | 122830-14-2 |
| Formula | C16H21N3 |
| Molar Mass | 255.36 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Natali A, et al. Effects of acute alpha 2-blockade on insulin action and secretion in humans. Am J Physiol. 1998 Jan;274(1 Pt 1):E57-64. |